TERLIEON 1MG/10ML INJECTION

TERLIEON 1mg/10ml Injection is a prescription medication containing terlipressin, a vasopressin analog used in emergency treatment of bleeding esophageal varices and hepatorenal syndrome. It works by constricting blood vessels in the portal circulation, helping reduce pressure in the portal vein and control life-threatening bleeding in patients with advanced liver disease.

This injection is administered in hospital settings under strict medical supervision. TERLIEON Injection helps stabilize patients by reducing active bleeding and improving kidney function in hepatorenal syndrome associated with severe liver disease. Its targeted action makes it an important supportive therapy in the critical care management of complications related to liver cirrhosis.

Patients receiving TERLIEON 1 mg/10 ml Injections require monitoring of blood pressure, heart function, and electrolyte levels during treatment. Some side effects may include abdominal cramps, headache, or changes in blood pressure. With proper medical care, TERLIEON Injection plays a crucial role in controlling bleeding, improving clinical outcomes, and supporting recovery in serious liver-related emergencies.

Product Features

• Contains terlipressin 1 mg
• Used for variceal bleeding control
• Supports the treatment of hepatorenal syndrome
• Rapid vasoconstrictor action
• Administered in hospital settings

How It Helps

• Reduces portal vein pressure
• Controls bleeding from esophageal varices
• Improves kidney function in liver disease
• Stabilizes patients in emergency care